FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312559231> ?p ?o ?g. }

• W4312559231 endingPage "e39045" @default.
• W4312559231 startingPage "e39045" @default.
• W4312559231 abstract "Disparities in COVID-19 information and vaccine access have emerged during the pandemic. Individuals from historically excluded communities (eg, Black and Latin American) experience disproportionately negative health outcomes related to COVID-19. Community gaps in COVID-19 education, social, and health care services (including vaccines) should be prioritized as a critical effort to end the pandemic. Misinformation created by the politicization of COVID-19 and related public health measures has magnified the pandemic's challenges, including access to health care, vaccination and testing efforts, as well as personal protective equipment. Information and Communication Technology (ICT) has been demonstrated to reduce the gaps of marginalization in education and access among communities. Chatbots are an increasingly present example of ICTs, particularly in health care and in relation to the COVID-19 pandemic.This project aimed to (1) follow an inclusive and theoretically driven design process to develop and test a COVID-19 information ICT bilingual (English and Spanish) chatbot tool named Ana and (2) characterize and evaluate user experiences of these innovative technologies.Ana was developed following a multitheoretical framework, and the project team was comprised of public health experts, behavioral scientists, community members, and medical team. A total of 7 iterations of ß chatbots were tested, and a total of 22 ß testers participated in this process. Content was curated primarily to provide users with factual answers to common questions about COVID-19. To ensure relevance of the content, topics were driven by community concerns and questions, as ascertained through research. Ana's repository of educational content was based on national and international organizations as well as interdisciplinary experts. In the context of this development and pilot project, we identified an evaluation framework to explore reach, engagement, and satisfaction.A total of 626 community members used Ana from August 2021 to March 2022. Among those participants, 346 used the English version, with an average of 43 users per month; and 280 participants used the Spanish version, with an average of 40 users monthly. Across all users, 63.87% (n=221) of English users and 22.14% (n=62) of Spanish users returned to use Ana at least once; 18.49% (n=64) among the English version users and 18.57% (n=52) among the Spanish version users reported their ranking. Positive ranking comprised the smiley and loved emojis, and negative ranking comprised the neutral, sad, and mad emojis. When comparing negative and positive experiences, the latter was higher across Ana's platforms (English: n=41, 64.06%; Spanish: n=41, 77.35%) versus the former (English: n=23, 35.93%; Spanish: n=12, 22.64%).This pilot project demonstrated the feasibility and capacity of an innovative ICT to share COVID-19 information within diverse communities. Creating a chatbot like Ana with bilingual content contributed to an equitable approach to address the lack of accessible COVID-19-related information." @default.
• W4312559231 created "2023-01-05" @default.
• W4312559231 creator A5000507898 @default.
• W4312559231 creator A5017460583 @default.
• W4312559231 creator A5017957067 @default.
• W4312559231 creator A5019060328 @default.
• W4312559231 creator A5024616724 @default.
• W4312559231 creator A5040881376 @default.
• W4312559231 creator A5079248276 @default.
• W4312559231 date "2023-01-25" @default.
• W4312559231 modified "2023-09-29" @default.
• W4312559231 title "COVID-19 Vaccine Equity and Access: Case Study for Health Care Chatbots" @default.
• W4312559231 cites W2017322496 @default.
• W4312559231 cites W2102136642 @default.
• W4312559231 cites W2135113045 @default.
• W4312559231 cites W2149236908 @default.
• W4312559231 cites W2332700952 @default.
• W4312559231 cites W2419516399 @default.
• W4312559231 cites W2608073811 @default.
• W4312559231 cites W2765672241 @default.
• W4312559231 cites W2900107703 @default.
• W4312559231 cites W2948196535 @default.
• W4312559231 cites W3018999878 @default.
• W4312559231 cites W3021999948 @default.
• W4312559231 cites W3044291841 @default.
• W4312559231 cites W3044464354 @default.
• W4312559231 cites W3045049308 @default.
• W4312559231 cites W3048100966 @default.
• W4312559231 cites W3049150623 @default.
• W4312559231 cites W3094976183 @default.
• W4312559231 cites W3098724043 @default.
• W4312559231 cites W3099369213 @default.
• W4312559231 cites W3124790762 @default.
• W4312559231 cites W3127125777 @default.
• W4312559231 cites W3164489398 @default.
• W4312559231 cites W3179475117 @default.
• W4312559231 cites W3181304496 @default.
• W4312559231 cites W3192913554 @default.
• W4312559231 cites W3199954533 @default.
• W4312559231 cites W3216401199 @default.
• W4312559231 cites W4200111036 @default.
• W4312559231 cites W4200206939 @default.
• W4312559231 cites W4225103613 @default.
• W4312559231 cites W4225663924 @default.
• W4312559231 cites W4294841143 @default.
• W4312559231 doi "https://doi.org/10.2196/39045" @default.
• W4312559231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36630649" @default.
• W4312559231 hasPublicationYear "2023" @default.
• W4312559231 type Work @default.
• W4312559231 citedByCount "1" @default.
• W4312559231 countsByYear W43125592312023 @default.
• W4312559231 crossrefType "journal-article" @default.
• W4312559231 hasAuthorship W4312559231A5000507898 @default.
• W4312559231 hasAuthorship W4312559231A5017460583 @default.
• W4312559231 hasAuthorship W4312559231A5017957067 @default.
• W4312559231 hasAuthorship W4312559231A5019060328 @default.
• W4312559231 hasAuthorship W4312559231A5024616724 @default.
• W4312559231 hasAuthorship W4312559231A5040881376 @default.
• W4312559231 hasAuthorship W4312559231A5079248276 @default.
• W4312559231 hasBestOaLocation W43125592311 @default.
• W4312559231 hasConcept C138816342 @default.
• W4312559231 hasConcept C142724271 @default.
• W4312559231 hasConcept C144133560 @default.
• W4312559231 hasConcept C15744967 @default.
• W4312559231 hasConcept C159110408 @default.
• W4312559231 hasConcept C160735492 @default.
• W4312559231 hasConcept C17744445 @default.
• W4312559231 hasConcept C199539241 @default.
• W4312559231 hasConcept C199728807 @default.
• W4312559231 hasConcept C2250968 @default.
• W4312559231 hasConcept C2776990098 @default.
• W4312559231 hasConcept C2779134260 @default.
• W4312559231 hasConcept C2779891985 @default.
• W4312559231 hasConcept C2781050511 @default.
• W4312559231 hasConcept C3008058167 @default.
• W4312559231 hasConcept C39549134 @default.
• W4312559231 hasConcept C509550671 @default.
• W4312559231 hasConcept C524204448 @default.
• W4312559231 hasConcept C71924100 @default.
• W4312559231 hasConcept C89623803 @default.
• W4312559231 hasConceptScore W4312559231C138816342 @default.
• W4312559231 hasConceptScore W4312559231C142724271 @default.
• W4312559231 hasConceptScore W4312559231C144133560 @default.
• W4312559231 hasConceptScore W4312559231C15744967 @default.
• W4312559231 hasConceptScore W4312559231C159110408 @default.
• W4312559231 hasConceptScore W4312559231C160735492 @default.
• W4312559231 hasConceptScore W4312559231C17744445 @default.
• W4312559231 hasConceptScore W4312559231C199539241 @default.
• W4312559231 hasConceptScore W4312559231C199728807 @default.
• W4312559231 hasConceptScore W4312559231C2250968 @default.
• W4312559231 hasConceptScore W4312559231C2776990098 @default.
• W4312559231 hasConceptScore W4312559231C2779134260 @default.
• W4312559231 hasConceptScore W4312559231C2779891985 @default.
• W4312559231 hasConceptScore W4312559231C2781050511 @default.
• W4312559231 hasConceptScore W4312559231C3008058167 @default.
• W4312559231 hasConceptScore W4312559231C39549134 @default.
• W4312559231 hasConceptScore W4312559231C509550671 @default.
• W4312559231 hasConceptScore W4312559231C524204448 @default.

• next